We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $36.82 · 11 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Genmab (Nasdaq: GMAB) director sells 526 shares on NASDAQ Copenhagen - Stock Titan
Genmab (Nasdaq: GMAB) director sells 526 shares on NASDAQ Copenhagen Stock Titan
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons - The Manila Times
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons The Manila Times
Genmab A/S stock (DK0010272202): Nasdaq Copenhagen shares little changed after recent cancer drug an - AD HOC NEWS
Genmab A/S stock (DK0010272202): Nasdaq Copenhagen shares little changed after recent cancer drug an AD HOC NEWS
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | After market close (AMC) | — | — | — | $6.95B | — | Scheduled |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 04. 30. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 03. 27. | Wolfe Research | — | Initiate coverage | — → Outperform | — | Wolfe Research: Outperform |
| 2026. 03. 02. | Wells Fargo | — | Initiate coverage | — → Overweight | — | Wells Fargo: Overweight |
| 2026. 02. 24. | Guggenheim | — | Maintain | Buy → Buy | — | Guggenheim: Buy |
| 2026. 02. 18. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 01. 28. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
Price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 2,339,432 | $62.77B | 0.05% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 895,843 | $27.59B | 0.04% | — | New position |